VN
ChemWerth Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Human APIs (Portfolio) | Various (Oncologicals, Antibiotics, Anti-inflammatories, etc.) | Approved |
| Veterinary APIs (Portfolio) | Various Animal Health Indications | Approved |
| Bag APIs | Various | Approved |
| Inhalation APIs | Respiratory Diseases | Approved |
| Injectable APIs | Various (Hospital, Critical Care) | Approved |
| Ophthalmic APIs | Eye Diseases | Approved |
| Oral APIs | Various | Approved |
| Topical APIs | Dermatological Conditions | Approved |
Leadership Team at ChemWerth
PJ
Peter J. Werth
Founder & Chairman
PW
Pete Werth III
President
DM
Dave Moore
Executive Vice President
VA
Vincent Asaro
Chief Financial Officer
MD
Marco D’Urso
Senior Vice President, Regulatory & Compliance
DX
Dr. Xiping Su
Senior Vice President, Scientific Affairs
MR
Madhu Rao
Strategic Business Partner, ChemWerth India
JY
Jim Yin
General Manager, ChemWerth China & Senior Advisor